2 withdrawn. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Withdrawn 2 |
Follow Enterocolitis, Pseudomembranous: new trials by email Literature Review of Enterocolitis, Pseudomembranous trials Research Report on Enterocolitis, Pseudomembranous
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bezlotoxumab Versus FMT for Multiple Recurrent CDI Bezlotoxumab, Fecal Microbiota Transplantation (FMT), Vancomycin oral - Clostridium Infections, Clostridioides Difficile | Phase 4 | Withdrawn | Leiden University Medical Center | 2022-01-01 | 2023-03-28 | |
| Addition of Lactobacillus to Metronidazole in Treatment of CDAD Lactobacillus GG - Enterocolitis, Pseudomembranous Colitis | Phase 4 | Withdrawn | Michael E. DeBakey VA Medical Center | 2008-08-01 | 2017-05-10 |
Clostridium Infections (1) · Enterocolitis (1)
Bacterial Infections (2) · Bacterial Infections and Mycoses (2) · Digestive System Diseases (2) · Gastroenteritis (2) · Gastrointestinal Diseases (2) · Gram-Positive Bacterial Infections (2) · Infections (2) · Intestinal Diseases (2) · Clostridium Infections (1) · Enterocolitis (1)
Fecal Microbiota Transplantation (1) · Lacteol (1) · Vancomycin (1) · bezlotoxumab (1)
Leiden University Medical Center (1) · Michael E. DeBakey VA Medical Center (1)
Netherlands (1) · United States (1)
Daniel M Musher, M.D. (1) · J van Prehn (1)